Trial Profile
Randomized, single dose, four period, cross-over open-label study to evaluate the pharmacokinetic parameters of 200 mg pirfenidone capsule versus pure pirfenidone 200 mg capsule (excluding excipients) versus 200 mg pirfenidone tablet versus 267 mg pirfenidone capsule in 32 healthy adults under fasting conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jul 2016
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Pharmacokinetics
- Sponsors AFT Pharmaceuticals
- 06 Jul 2016 Status changed from not yet recruiting to completed.
- 09 Sep 2015 New trial record